Abbott has received a CE mark for an insertable cardiac monitor (ICM) with a six-year battery life, the company said Monday.

The Assert-IQ ICM monitors a patient’s heart continuously to detect arrhythmias for either three or six years. Abbott sees the six-year option as suitable for longer-term monitoring of people at risk of developing arrhythmias.

Assert-IQ’s six-year battery life exceeds the 4.5-year lifespan of Medtronic’s Linq II device. The batteries in Biotronik’s Biomonitor III and Boston Scientific’s Lux-Dx II last for four years and three years, respectively.